The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe Omar Mian lab studies the genetic and epigenetic mechanisms underlying lethal genitourinary cancers.
Learn MoreThe new Cleveland Clinic-developed model incorporates how evolution contributes to drug effectiveness and dosage.
The discovery, made by a collaborative group of Cleveland Clinic researchers, opens the door to new avenues of research and reveals promising drug targets.
Preliminary research shows that drugs used to treat blood and neurological disorders can be repurposed to treat chemorefractory lung cancer.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers